(Q39213927)

English

Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease

scientific article published on March 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

inflammatory bowel diseases

0 references

0 references

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

Gilaad G. Kaplan

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Remo Panaccione

4

object named as

Remo Panaccione

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

Martin Storr

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Shane Devlin

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Christopher N Andrews

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

1 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

472-480

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Natural history and complications of IBD.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Evolving paradigms in the pathogenesis of IBD.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Inflammation in the intestinal tract: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Advances in the management of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Prospects for cannabinoids as anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabinoids and the gut: new developments and emerging concepts

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

The endogenous cannabinoid system protects against colonic inflammation

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Involvement of cannabinoid receptors in gut motility and visceral perception

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cross-national comparison of adolescent drinking and cannabis use in the United States, Canada, and the Netherlands

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabis use amongst patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabis use in sickle cell disease: a questionnaire study

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabis use in HIV for pain and other medical symptoms

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

The endocannabinoid system and gut-brain signalling.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Effects of current and former cigarette smoking on the clinical course of Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

The 10 remaining mysteries of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Influence of cannabis use on severity of hepatitis C disease

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Recent clinical experience with dronabinol

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000440982.79036.D6

21 January 2018

Identifiers

10.1097/01.MIB.0000440982.79036.D6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

release_pijdr4rpqvcwpcqwh6qrq7nvlq

1 reference

https://api.fatcat.wiki/v0/release/pijdr4rpqvcwpcqwh6qrq7nvlq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39213927&oldid=1836409813"